Avalon Ventures XI, L.P.
SEC insider (Form 3/4/5 filer). CIK 0001652901. 10% Owner at Janux Therapeutics, Inc. (JANX). 64 reported Form 4/5 transactions since Sep 2024; latest on Oct 18, 2024. Located in LA JOLLA, CA.
Companies Avalon Ventures XI, L.P. has filed insider reports for
- Janux Therapeutics, Inc. (JANX): 10% Owner
Avalon Ventures XI, L.P.
CIK: 0001652901
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Janux Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (64 total)
- Oct 18, 2024JANX
Janux Therapeutics, Inc.
SaleIndirect553.2K shares at avg. $44.75$24.8M - Oct 18, 2024JANX
Janux Therapeutics, Inc.
SaleDirect15.5K shares at avg. $51.18$791K - Oct 18, 2024JANX
Janux Therapeutics, Inc.
SaleIndirect15.8K shares at avg. $51.18$808K - Oct 18, 2024JANX
Janux Therapeutics, Inc.
SaleIndirect105K shares at avg. $44.75$4.7M - Oct 18, 2024JANX
Janux Therapeutics, Inc.
SaleIndirect19.9K shares at avg. $50.30$1.0M - Oct 18, 2024JANX
Janux Therapeutics, Inc.
SaleIndirect104.9K shares at avg. $50.30$5.3M - Oct 18, 2024JANX
Janux Therapeutics, Inc.
SaleDirect102.7K shares at avg. $50.30$5.2M - Oct 18, 2024JANX
Janux Therapeutics, Inc.
SaleIndirect3K shares at avg. $51.18$153K - Oct 18, 2024JANX
Janux Therapeutics, Inc.
SaleDirect541.8K shares at avg. $44.75$24.2M - Oct 17, 2024JANX
Janux Therapeutics, Inc.
ExerciseDirect237 shares at avg. $39.80$9K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 18, 2024 | JANX Janux Therapeutics, Inc. | Sale | 553,219 | $44.75 | $24,756,550 | Indirect |
| Oct 18, 2024 | JANX Janux Therapeutics, Inc. | Sale | 15,462 | $51.18 | $791,345 | Direct |
| Oct 18, 2024 | JANX Janux Therapeutics, Inc. | Sale | 15,788 | $51.18 | $808,030 | Indirect |
| Oct 18, 2024 | JANX Janux Therapeutics, Inc. | Sale | 104,957 | $44.75 | $4,696,826 | Indirect |
| Oct 18, 2024 | JANX Janux Therapeutics, Inc. | Sale | 19,900 | $50.30 | $1,000,970 | Indirect |
| Oct 18, 2024 | JANX Janux Therapeutics, Inc. | Sale | 104,892 | $50.30 | $5,276,068 | Indirect |
| Oct 18, 2024 | JANX Janux Therapeutics, Inc. | Sale | 102,732 | $50.30 | $5,167,420 | Direct |
| Oct 18, 2024 | JANX Janux Therapeutics, Inc. | Sale | 2,995 | $51.18 | $153,284 | Indirect |
| Oct 18, 2024 | JANX Janux Therapeutics, Inc. | Sale | 541,824 | $44.75 | $24,246,624 | Direct |
| Oct 17, 2024 | JANX Janux Therapeutics, Inc. | Exercise | 237 | $39.80 | $9,433 | Direct |
1-10 of 64 transactions